# Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma

> **NCT06730308** · PHASE2 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 45 (estimated)

## Conditions studied

- Thymoma

## Interventions

- **RADIATION:** Radiotherapy
- **DRUG:** Concurrent chemotherapy
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT06730308
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-20
- **Primary completion:** 2028-11-19
- **Final completion:** 2028-11-19
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06730308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06730308, "Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06730308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*